Evolutionary Genomics

Evolutionary Genomics R&D Expenses

The Research & Development Expenses of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is 417,450.00 USD. In the previous year, Research & Development Expenses was 1.23 M USD — a change of -66.18% (lower).

R&D Expenses

417,450.00USD

YoY

-66.18%

Last updated:

Research & Development Expenses of Evolutionary Genomics is 2022 417,450.00 USD. Research & Development Expenses of Evolutionary Genomics was 2021 1.23 M USD. It decreases by -66.18% lower compared to the previous year.

The Evolutionary Genomics R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2015
416,160.00 USD
Jan 1, 2016
719,900.00 USD
Jan 1, 2017
791,060.00 USD
Jan 1, 2018
473,992.00 USD
Jan 1, 2019
472,613.00 USD
Jan 1, 2020
1.79 M USD
Jan 1, 2021
1.23 M USD
Jan 1, 2022
417,450.00 USD
The Evolutionary Genomics R&D Expenses history
YEARR&D ExpensesYoY
417,450.00USD-66.18%
1.23 MUSD-31.17%
1.79 MUSD+279.41%
472,613.00USD-0.29%
473,992.00USD-40.08%
791,060.00USD+9.88%
719,900.00USD+72.99%
416,160.00USD+259.61%
115,725.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

Research & Development Expenses of Evolutionary Genomics is 417,450.00 USD in 2022.

Research & Development Expenses of Evolutionary Genomics changed from 1.23 M USD to 417,450.00 USD, representing a -66.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics